Orkin et al “Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy”, Dec. 1995.* |
Ledley et al. Pharmaceutical Research. 13: 1595-1613, Nov. 1996.* |
Verma et al. Nature. 389: 239-242, Sep. 1997.* |
Wisniewski et al. Biochemistry. 33: 7423-7429, Jun. 1994.* |
Miller et al. FASEB J. 9: 190-199, Feb. 1995.* |
Takakura et al. Pharmaceutical Research. 13(6): 820-31, Jun. 1996.* |
Klampfer, Lidija et al., “NF-IL6 and AP-1 cooperatively modulate the activation of the TSG-6 gene by tumor necrosis factor alpha and interleukin-1”. Molecular and Cellular Biology, vol. 14, No. 10, pp. 6561-6569. |
Journal of Immunology, vol. 150 (08 Part 02), issued May 21-25, 1993, “TSG-6: A cytokine and LPS-inducible secreted 35 KDA glycoprotein associated with arthritis and inflammation.” abs. 127 A. |
Journal of Cellular Biochemistry, (18 Part A), issued Jan. 16-23, 1994, Wisniewski et al., “TSG-6, An arthritis-associated hyaluronan binding protein, forms a stable complex with inter-alpha-inhibitor VIA a glycosaminoglycan crosslink”, pp. 338, abs. #EZ508. |